Pharmacokinetics of mizoribine in renal transplant patients.
作者信息
Kokado Y, Takahara S, Ishibashi M, Okuyama A
机构信息
Department of Urology, Osaka University Hospital, Japan.
出版信息
Transplant Proc. 1994 Aug;26(4):2111-3.
PMID:8066687
Abstract
摘要
相似文献
1
Pharmacokinetics of mizoribine in renal transplant patients.
Transplant Proc. 1994 Aug;26(4):2111-3.
2
Influence of bioavailability on blood level of mizoribine in kidney transplant recipients.
Transplant Proc. 1996 Jun;28(3):1321-3.
3
Clinical pharmacokinetic study of mizoribine in renal transplantation patients.
Transplant Proc. 1996 Dec;28(6):3643-8.
4
Clinical significance of blood level monitoring of mizoribine in kidney transplantation.
Transplant Proc. 1994 Aug;26(4):2029-31.
5
Immunosuppression with low-dose cyclosporine, mizoribine, and steroids in living-related kidney transplantation.
Transplant Proc. 1994 Aug;26(4):1907-9.
6
Immunosuppressive therapy using CsA, MZ, steroids, and DSG during the early phase after kidney grafting, with later steroid withdrawal.
Transplant Proc. 1994 Aug;26(4):2065-6.
7
Clinical use of mizoribine (Bredinin) and pharmacologic monitoring assessment in renal transplantation.
Transplant Proc. 1995 Feb;27(1):1064-5.
8
Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
Transplant Proc. 1996 Dec;28(6):3343-4.
9
Clinical experience of FK 506 for renal allograft transplantation.
Transplant Proc. 1994 Aug;26(4):1924-6.
10
Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
Transplant Proc. 1996 Aug;28(4):2165-8.
引用本文的文献
1
Prediction of mizoribine pharmacokinetic parameters by serum creatinine in renal transplant recipients.
Eur J Clin Pharmacol. 2019 Mar;75(3):363-369. doi: 10.1007/s00228-018-2584-4. Epub 2018 Nov 1.
2
Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.
Clin Pharmacokinet. 2002;41(2):115-35. doi: 10.2165/00003088-200241020-00004.
Zotero 插件